Abstract
A new series of 3-hydroxyquinoline derivatives 2a-c has been synthesized by decarboxylation of corresponding quinoline-4-carboxylic acid derivatives 1a-c. These 3-hydroxyquinolines have been subjected to a number of electrophilic aromatic substitution reactions (SEAr) at C4 to obtain the target structures; 3, 4, 7, 8 and 10 through: bromination, formylation, Mannich reaction, coupling with diazonium salt and acylation, respectively. In addition, formation of fused pyrano[2,3-c]quinolin-3-one 5 and chalcone 11 were done. Trials for formation of chalcone analogue 6 were failed indicating 100% of 3-hydroxy tautomer of 2a-c. All the obtained compounds can act as good chelators and contain at least 3 H-bond acceptor groups. All compounds were evaluated for antioxidant activity by ABTS assay.
Keywords: 3-Hydroxyquinolines, electrophilic aromatic substitution, antioxidant, ABTS assay.
Graphical Abstract
Letters in Organic Chemistry
Title:New Synthons of 3-Hydroxyquinoline Derivatives Through SEAr
Volume: 11 Issue: 9
Author(s): Mohammed A. M. Massoud, Serry A. El Bialy, Waleed A. Bayoumi and Walaa M. El Husseiny
Affiliation:
Keywords: 3-Hydroxyquinolines, electrophilic aromatic substitution, antioxidant, ABTS assay.
Abstract: A new series of 3-hydroxyquinoline derivatives 2a-c has been synthesized by decarboxylation of corresponding quinoline-4-carboxylic acid derivatives 1a-c. These 3-hydroxyquinolines have been subjected to a number of electrophilic aromatic substitution reactions (SEAr) at C4 to obtain the target structures; 3, 4, 7, 8 and 10 through: bromination, formylation, Mannich reaction, coupling with diazonium salt and acylation, respectively. In addition, formation of fused pyrano[2,3-c]quinolin-3-one 5 and chalcone 11 were done. Trials for formation of chalcone analogue 6 were failed indicating 100% of 3-hydroxy tautomer of 2a-c. All the obtained compounds can act as good chelators and contain at least 3 H-bond acceptor groups. All compounds were evaluated for antioxidant activity by ABTS assay.
Export Options
About this article
Cite this article as:
Massoud A. M. Mohammed, Bialy A. El Serry, Bayoumi A. Waleed and Husseiny M. El Walaa, New Synthons of 3-Hydroxyquinoline Derivatives Through SEAr, Letters in Organic Chemistry 2014; 11 (9) . https://dx.doi.org/10.2174/157017861109140903105543
DOI https://dx.doi.org/10.2174/157017861109140903105543 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD): An Update [1]
Medicinal Chemistry Reviews - Online (Discontinued) Meet Our Editorial Board Member
Current Medicinal Chemistry Gadolinium-based Imaging Contrast Agents
Current Medical Imaging Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Current Molecular Pharmacology Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Current Psychopharmacology Speech Recognition Using Elman Artificial Neural Network and Linear Predictive Coding
Recent Advances in Computer Science and Communications Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes
Current Medicinal Chemistry Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research Understanding the Structural Basis of ALDH-2 Inhibition by Molecular Docking
Medicinal Chemistry Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Current Pharmaceutical Design Peripartum Cardiomyopathy: Moving Towards a More Central Role of Genetics
Current Cardiology Reviews The Effect of Acori Graminei Rhizoma and Extract Fractions on Spatial Memory and Hippocampal Neurogenesis in Amyloid Beta 1-42 Injected Mice
CNS & Neurological Disorders - Drug Targets Structure-Function of Prolyl Oligopeptidase and its Role in Neurological Disorders
Current Medicinal Chemistry - Central Nervous System Agents Cannabinoid-Opioid Interactions in Drug Discrimination and Self-Administration: Effect of Maternal, Postnatal, Adolescent and Adult Exposure to the Drugs
Current Drug Targets Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness
Current Alzheimer Research Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery CB1 Cannabinoid Antagonists: Structure-Activity Relationships and Potential Therapeutic Applications
Current Topics in Medicinal Chemistry